These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38890811)
21. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol. Curran K; Thamm DH Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs. Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176 [TBL] [Abstract][Full Text] [Related]
24. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma. Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727 [TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide and prednisolone for chemotherapy naïve B cell multicentric lymphoma in dogs: 32 cases (2017-2021). Todd J; Thomas P; Nguyen S J Small Anim Pract; 2022 Jan; 63(1):52-55. PubMed ID: 34647324 [TBL] [Abstract][Full Text] [Related]
26. Use of lomustine (CCNU) in a case of cutaneous equine lymphoma. Doyle AJ; MacDonald VS; Bourque A Can Vet J; 2013 Dec; 54(12):1137-41. PubMed ID: 24293673 [TBL] [Abstract][Full Text] [Related]
27. LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus. Horta RS; Souza LM; Sena BV; Almeida IO; Jaretta TA; Pimenta MM; Reche Júnior A J Feline Med Surg; 2021 Feb; 23(2):86-97. PubMed ID: 32684120 [TBL] [Abstract][Full Text] [Related]
28. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017). Moirano SJ; Dewey CW; Wright KZ; Cohen PW Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768 [TBL] [Abstract][Full Text] [Related]
29. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. Wang SL; Lee JJ; Liao AT Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263 [TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of clinical presentation, induction and rescue treatment in 42 cases of canine centroblastic diffuse large B-cell multicentric lymphoma in the United Kingdom. Davies O; Szladovits B; Polton G; Garden OA; Leo C; Lara-Garcia A Vet Comp Oncol; 2018 Jun; 16(2):276-287. PubMed ID: 29271043 [TBL] [Abstract][Full Text] [Related]
31. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): a retrospective study of 46 cases (1999-2004). Risbon RE; de Lorimier LP; Skorupski K; Burgess KE; Bergman PJ; Carreras J; Hahn K; Leblanc A; Turek M; Impellizeri J; Fred R; Wojcieszyn JW; Drobatz K; Clifford CA J Vet Intern Med; 2006; 20(6):1389-97. PubMed ID: 17186855 [TBL] [Abstract][Full Text] [Related]
32. Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy. Mason SL; Finotello R; Blackwood L Vet Comp Oncol; 2018 Mar; 16(1):E30-E37. PubMed ID: 28621004 [TBL] [Abstract][Full Text] [Related]
33. Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study. Lori JC; Stein TJ; Thamm DH Vet Comp Oncol; 2010 Sep; 8(3):188-95. PubMed ID: 20691026 [TBL] [Abstract][Full Text] [Related]
34. Oral melphalan for the treatment of relapsed canine lymphoma. Mastromauro ML; Suter SE; Hauck ML; Hess PR Vet Comp Oncol; 2018 Mar; 16(1):E123-E129. PubMed ID: 28941072 [TBL] [Abstract][Full Text] [Related]
35. Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma. O'Connell K; Thomson M; Morgan E; Henning J Vet Comp Oncol; 2022 Sep; 20(3):613-622. PubMed ID: 35338560 [TBL] [Abstract][Full Text] [Related]
36. Epirubicin as part of a multi-agent chemotherapy protocol for canine lymphoma. Elliott JW; Cripps P; Marrington AM; Grant IA; Blackwood L Vet Comp Oncol; 2013 Sep; 11(3):185-98. PubMed ID: 22372620 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma. Webster J; McNaught KA; Morris JS J Feline Med Surg; 2024 Apr; 26(4):1098612X241234614. PubMed ID: 38647264 [TBL] [Abstract][Full Text] [Related]
38. Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014). Lenz JA; Robat CS; Stein TJ J Small Anim Pract; 2016 Aug; 57(8):429-34. PubMed ID: 27251593 [TBL] [Abstract][Full Text] [Related]
39. Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012). Lejeune A; Skorupski K; Frazier S; Vanhaezebrouck I; Rebhun RB; Reilly CM; Rodriguez CO Vet Comp Oncol; 2015 Sep; 13(3):267-80. PubMed ID: 23721492 [TBL] [Abstract][Full Text] [Related]
40. Rectal lymphoma in 11 dogs: a retrospective study. Van den Steen N; Berlato D; Polton G; Dobson J; Stewart J; Maglennon G; Hayes AM; Murphy S J Small Anim Pract; 2012 Oct; 53(10):586-91. PubMed ID: 22882127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]